What is the total expected cost of Colgate's new productivity program, and when will it be incurred?

The three-year Productivity Program is projected to generate cumulative pre-tax charges of $200 to $300 million once all initiatives are approved and implemented. Substantially all of these charges are expected to be incurred by December 31, 2028, and will be recorded in the Corporate segment rather than in individual business segments.

Why did organic sales growth slow, and what is the outlook for the rest of 2025?

Organic sales grew 1.8% in the second quarter, but this included a 0.6-point drag from lower private label pet sales, which the company is exiting. Management now expects full-year organic sales growth at the low end of its 2% to 4% range, reflecting volatile category growth and uncertain global markets. Organic volume was flat for the total company, so growth relied on pricing of about 2%.

Did margins hold up in the quarter?

Not fully. GAAP gross margin fell 50 basis points to 60.1%, and Base Business gross margin fell 70 basis points. Base Business operating margin declined 80 basis points to 21.3%, with Latin America and North America showing the largest profit declines. Management still expects gross margin and advertising spend to be roughly flat as a percentage of sales for the full year.

Is Colgate's balance sheet or cash generation a concern?

Total debt increased to $8.76 billion from $7.95 billion at year-end 2024, and first-half free cash flow before dividends fell to $1.25 billion from $1.43 billion, mainly due to working capital outflows. Net debt (debt less cash and marketable securities) rose to $7.35 billion. Dividends paid of $880 million in the first half were not fully covered by free cash flow, although the company still generated $1.48 billion in operating cash flow.

CL 8-K: Earnings & Results & Financial Events

01—Abstract

Summary

Summary of the 8-K filed August 1, 2025. Cited figures are marked; the original filing is the authoritative source.

Colgate-Palmolive reported second-quarter 2025 results that were modestly positive at the top and bottom line but showed underlying pressure.

GAAP net sales rose 1.0% to $5.11 billion^a, and organic sales grew 1.8%, though that figure absorbed a 0.6-point drag from the planned exit of private label pet sales. GAAP diluted EPS rose 2% to $0.91, while Base Business (non-GAAP) EPS rose 1% to $0.92. Gross margin contracted 50 basis points on a GAAP basis (70 bps on a Base Business basis), and Base Business operating margin fell 80 bps to 21.3%.

Growth was uneven by region: Latin America and North America were weak in organic terms and Asia Pacific was flat, while Hill's (Pet Nutrition) and Africa/Eurasia were the strongest performers. Management narrowed its full-year 2025 organic sales growth guidance to the low end of its 2%^b to 4% range, a signal of softer demand, while keeping its guidance for roughly flat gross margin and advertising as a percentage of sales and low-single-digit EPS growth. The company also announced a new three-year productivity program, approved July 31, 2025, tied to its 2030 strategy.

It is expected to generate cumulative pre-tax charges of $200 to $300 million^c, with substantially all charges recognized by December 31, 2028, and recorded in the Corporate segment. Investors should weigh near-term restructuring costs against the potential margin and cost benefits from simplifying the organization and optimizing the supply chain.

Free cash flow before dividends was $1.25 billion^d for the first half of 2025, down from $1.43 billion a year earlier, and total debt rose to $8.76 billion from $7.95 billion at year-end 2024, partly reflecting a 2025 acquisition (Prime100 pet food). Overall, the quarter shows resilient earnings and share-count-driven EPS growth against a backdrop of slowing organic growth, margin pressure, and a new cost program that management expects to weigh on reported results through 2028.

02—Key points

Key Highlights

GAAP net sales increased 1.0% to $5,110 million; organic sales grew 1.8%, including a 0.6-point negative impact from lower private label pet sales.
GAAP diluted EPS rose 2% to $0.91; Base Business EPS rose 1% to $0.92.
Gross margin declined 50 bps (GAAP) to 60.1%, and Base Business operating margin fell 80 bps to 21.3%, reflecting pricing and cost pressures.
Full-year 2025 organic sales growth guidance was narrowed to the low end of the 2% to 4% range, while EPS guidance of low-single-digit growth was maintained.
New three-year productivity program (approved July 31, 2025) expected to cost $200 to $300 million in pre-tax charges, substantially all incurred by December 31, 2028.
Hill's Pet Nutrition (+2.0% organic, operating profit +13%) and Europe (+2.0% organic, operating profit +9%) were the strongest divisions, while Latin America (operating profit -12%) and North America (operating profit -9%) weakened.
Total debt rose to $8,758 million at June 30, 2025, from $7,949 million at year-end 2024, and first-half free cash flow before dividends declined to $1,252 million from $1,428 million.

03—Questions

Frequently Asked Questions

What is the total expected cost of Colgate's new productivity program, and when will it be incurred?
The three-year Productivity Program is projected to generate cumulative pre-tax charges of $200 to $300 million once all initiatives are approved and implemented. Substantially all of these charges are expected to be incurred by December 31, 2028, and will be recorded in the Corporate segment rather than in individual business segments.
Why did organic sales growth slow, and what is the outlook for the rest of 2025?
Organic sales grew 1.8% in the second quarter, but this included a 0.6-point drag from lower private label pet sales, which the company is exiting. Management now expects full-year organic sales growth at the low end of its 2% to 4% range, reflecting volatile category growth and uncertain global markets. Organic volume was flat for the total company, so growth relied on pricing of about 2%.
Did margins hold up in the quarter?
Not fully. GAAP gross margin fell 50 basis points to 60.1%, and Base Business gross margin fell 70 basis points. Base Business operating margin declined 80 basis points to 21.3%, with Latin America and North America showing the largest profit declines. Management still expects gross margin and advertising spend to be roughly flat as a percentage of sales for the full year.
Is Colgate's balance sheet or cash generation a concern?
Total debt increased to $8.76 billion from $7.95 billion at year-end 2024, and first-half free cash flow before dividends fell to $1.25 billion from $1.43 billion, mainly due to working capital outflows. Net debt (debt less cash and marketable securities) rose to $7.35 billion. Dividends paid of $880 million in the first half were not fully covered by free cash flow, although the company still generated $1.48 billion in operating cash flow.

04—Continue

← View all 8-K filings